The HHS Thursday froze the former Trump administration’s December drug policy that requires community health centers to pass on all their insulin and epinephrine discount savings to patients.
Centers that don’t pass on the savings wouldn’t qualify for federal grants. The rule, which was finalized in late December, is delayed until March 22, the Department of Health and Human Services said in a Federal Register post.
This freeze is part of the Biden administration’s large-scale effort announced this week that will scrutinize the Trump administration’s health policies
Biden’s HHS Freezes Trump Insulin, Epinephrine Rule Until March
Perhaps the Trump order applied to plans other than Medicare Part D, but how can this clown change programs in mid-stream?
At least Trump's deal didn't go into effect until January 1.
Centers that don’t pass on the savings wouldn’t qualify for federal grants. The rule, which was finalized in late December, is delayed until March 22, the Department of Health and Human Services said in a Federal Register post.
This freeze is part of the Biden administration’s large-scale effort announced this week that will scrutinize the Trump administration’s health policies
Biden’s HHS Freezes Trump Insulin, Epinephrine Rule Until March
Perhaps the Trump order applied to plans other than Medicare Part D, but how can this clown change programs in mid-stream?
At least Trump's deal didn't go into effect until January 1.